Effects of heavy endurance physical exercise on inflammatory markers in non-athletes

Atherosclerosis

Volumn 209, Issue 2, 2010, Pages 601-605

  Andersson, Jonas ^a   Jansson, Jan Håkan ^a   Hellsten, Gideon ^c   Nilsson, Torbjörn K ^d   Hallmans, Göran ^b   Boman, Kurt ^a  

^a Skelleftea Hospital   (Sweden)

^b UMEÅ UNIVERSITY   (Sweden)

^c Norsjö Primary Health Care Center   (Sweden)

^d ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

Author keywords

C reactive protein; Exercise; Inflammation; Interleukin 6; Tumor necrosis factor alpha

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONTROLLED STUDY; ENDURANCE; EXERCISE INTENSITY; EXERCISE RECOVERY; FAT INTAKE; HUMAN; HUMAN EXPERIMENT; INFLAMMATION; MALE; NORMAL HUMAN; PHYSICAL ACTIVITY; PRIORITY JOURNAL; SKIING;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIETARY FATS; EXERCISE; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; PHYSICAL ENDURANCE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77950023623     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.10.025     Document Type: Article

References (24)

1. Paffenbarger R.S.J., Hyde R.T., Wing A.L., et al. The association of changes in physical-activity level and other lifestyle characteristics with mortality among men. N Engl J Med 1993, 328:538-545.
2. Pate R.R., Pratt M., Blair S.N., et al. Physical activity and public health. A recommendation from the centers for disease control and prevention and the American college of sports medicine. JAMA 1995, 273:402-407.
3. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the health abc study. Circulation 2003, 108:2317-2322.
4. Tuomisto K., Jousilahti P., Sundvall J., Pajunen P., Salomaa V. C-reactive protein, interleukin-6 and tumor necrosis factor alpha as predictors of incident coronary and cardiovascular events and total mortality. A population-based, prospective study. Thromb Haemost 2006, 95:511-518.
5. Abramson J.L., Vaccarino V. Relationship between physical activity and inflammation among apparently healthy middle-aged and older us adults. Arch Intern Med 2002, 162:1286-1292.
6. Ford E.S. Does exercise reduce inflammation? Physical activity and c-reactive protein among U.S. adults. Epidemiology 2002, 13:561-568.
7. Mora S., Cook N., Buring J.E., Ridker P.M., Lee I.M. Physical activity and reduced risk of cardiovascular events: potential mediating mechanisms. Circulation 2007, 116:2110-2118.
8. Kasapis C., Thompson P.D. The effects of physical activity on serum c-reactive protein and inflammatory markers: a systematic review. J Am Coll Cardiol 2005, 45(10):1563-1569.
9. Kelley G.A., Kelley K.S. Effects of aerobic exercise on c-reactive protein, body composition, and maximum oxygen consumption in adults: a meta-analysis of randomized controlled trials. Metabolism 2006, 55:1500-1507.
10. Boman K., Hellsten G., Bruce A., Hallmans G., Nilsson T.K. Endurance physical activity, diet and fibrinolysis. Atherosclerosis 1994, 106:65-74.
11. Weinehall L., Westman G., Hellsten G., et al. Shifting the distribution of risk: results of a community intervention in a Swedish programme for the prevention of cardiovascular disease. J Epidemiol Community Health 1999, 53:243-250.
12. Livsmedelsverket Livsmedelsverkets menybok 2004, Elanders Gotab, Stockholm.
13. Lakka T.A., Lakka H.M., Rankinen T., et al. Effect of exercise training on plasma levels of c-reactive protein in healthy adults: the heritage family study. Eur Heart J 2005, 26:2018-2025.
14. Mattusch F., Dufaux B., Heine O., Mertens I., Rost R. Reduction of the plasma concentration of c-reactive protein following nine months of endurance training. Int J Sports Med 2000, 21:21-24.
15. Fischer C.P., Berntsen A., Perstrup L.B., Eskildsen P., Pedersen B.K. Plasma levels of interleukin-6 and c-reactive protein are associated with physical inactivity independent of obesity. Scand J Med Sci Sports 2007, 17:580-587.
16. Fischer C.P. Interleukin-6 in acute exercise and training: what is the biological relevance?. Exerc Immunol Rev 2006, 12:6-33.
17. Bastard J.P., Maachi M., Nhieu J.T.V., et al. Adipose tissue il-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
18. Petersen A.M., Pedersen P.K. The anti-inflammatory effect of exercise. J Appl Physiol 2005, 98:1154-1162.
19. Pedersen B.K., Hoffman-Goetz L. Exercise and the immune system: regulation, integration, and adaptation. Physiol Rev 2000, 80:1055-1081.
20. Pedersen B.K., Steensberg A., Schjerling P. Muscle-derived interleukin-6: possible biological effects. J Physiol 2001, 536:329-337.
21. Ross R. Mechanisms of disease: atherosclerosis-an inflammatory disease. N Engl J Med 1999, 340:115-126.
22. Tamakoshi K., Yatsuya H., Kondo T., et al. The metabolic syndrome is associated with elevated circulating c-reactive protein in healthy reference range, a systemic low-grade inflammatory state. Int J Obes Relat Metab Disord 2003, 27:443-449.
23. Genser B., Grammer T., Stojakovic T., Siekmeier R., Maerz W. Effect of hmg coa reductase inhibitors on low-density lipoprotein cholesterol and c-reactive protein: systematic review and meta-analysis. Int J Clin Pharmacol Ther 2008, 46:497-510.
24. Kinlay S. Low-density lipoprotein-dependent and -independent effects of cholesterol-lowering therapies on c-reactive protein: a meta-analysis. J Am Coll Cardiol 2007, 49:2003-2009.